Reducing global risk for cardiovascular disease: Using lifestyle changes and pharmacotherapy

Alan Cheng, Joel B. Braunstein, Cheryl Dennison, Caitlin Nass, Roger S. Blumenthal

Research output: Contribution to journalReview articlepeer-review

26 Scopus citations


Cardiovascular disease (CVD) is the leading cause of death and disability in industrialized societies, due in large part to the lack of a comprehensive approach to control the risk factors for atherosclerosis. One strategy for reducing an individual's global CVD risk relies on a targeted approach that modifies each of the major independent risk factors prevalent in both symptomatic (secondary prevention) and asymptomatic (primary prevention) patients. These interventions include lipid lowering, smoking cessation, blood pressure control, glycemic control, regular exercise, and the use of various medications. This review offers an evidence-based strategy toward reducing an individual's global risk for CVD by addressing the modifiable, major independent risk factors.

Original languageEnglish (US)
Pages (from-to)205-212
Number of pages8
JournalClinical Cardiology
Issue number5
StatePublished - 2002


  • Hypertension
  • Lifestyle
  • Lipids
  • Prevention
  • Risk factors

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Reducing global risk for cardiovascular disease: Using lifestyle changes and pharmacotherapy'. Together they form a unique fingerprint.

Cite this